On October 11, MyMD Pharmaceuticals Inc Received Letter From Nasdaq Indicating Company Did Not Meet Minimum Bid Price Requirement
Portfolio Pulse from Benzinga Newsdesk
MyMD Pharmaceuticals Inc has received a letter from Nasdaq indicating that the company did not meet the minimum bid price requirement, according to an SEC filing.

October 13, 2023 | 9:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
MyMD Pharmaceuticals Inc did not meet the minimum bid price requirement set by Nasdaq, which could potentially lead to delisting if not rectified.
Failing to meet the minimum bid price requirement is a serious issue as it could lead to the company's stock being delisted from the Nasdaq exchange. This would make the stock less accessible to investors, potentially leading to a decrease in demand and a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100